Black Diamond Therapeutics Inc (BDTX) kicked off at the price of $2.35: Venture capitalists have an exciting new opportunity

Black Diamond Therapeutics Inc (NASDAQ: BDTX) kicked off on Friday, down -4.47% from the previous trading day, before settling in for the closing price of $2.46. Over the past 52 weeks, BDTX has traded in a range of $1.20-$6.75.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales drop of Healthcare Sector giant was -5.22%. While this was happening, its average annual earnings per share was recorded 119.16%. With a float of $43.28 million, this company’s outstanding shares have now reached $56.68 million.

Let’s determine the extent of company efficiency that accounts for 24 employees. In terms of profitability, gross margin is 99.75%, operating margin of -5.72%, and the pretax margin is 7.27%.

Black Diamond Therapeutics Inc (BDTX) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Black Diamond Therapeutics Inc is 23.88%, while institutional ownership is 62.07%. The most recent insider transaction that took place on Mar 19 ’25, was worth 11,997,749. In this transaction 10% Owner of this company sold 5,784,292 shares at a rate of $2.07, taking the stock ownership to the 2,733,547 shares. Before that another transaction happened on Aug 28 ’24, when Company’s 10% Owner sold 221,600 for $6.32, making the entire transaction worth $1,400,556. This insider now owns 3,726,341 shares in total.

Black Diamond Therapeutics Inc (BDTX) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 119.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.33% during the next five years compared to -5.22% drop over the previous five years of trading.

Black Diamond Therapeutics Inc (NASDAQ: BDTX) Trading Performance Indicators

Take a look at Black Diamond Therapeutics Inc’s (BDTX) current performance indicators. Last quarter, stock had a quick ratio of 9.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.91.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.06, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.02 in one year’s time.

Technical Analysis of Black Diamond Therapeutics Inc (BDTX)

Looking closely at Black Diamond Therapeutics Inc (NASDAQ: BDTX), its last 5-days average volume was 2.11 million, which is a drop from its year-to-date volume of 2.29 million. As of the previous 9 days, the stock’s Stochastic %D was 56.55%.

During the past 100 days, Black Diamond Therapeutics Inc’s (BDTX) raw stochastic average was set at 72.78%, which indicates a significant increase from 35.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.45% in the past 14 days, which was lower than the 79.32% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.03, while its 200-day Moving Average is $2.51. However, in the short run, Black Diamond Therapeutics Inc’s stock first resistance to watch stands at $2.49. Second resistance stands at $2.62. The third major resistance level sits at $2.70. If the price goes on to break the first support level at $2.28, it is likely to go to the next support level at $2.20. Now, if the price goes above the second support level, the third support stands at $2.07.

Black Diamond Therapeutics Inc (NASDAQ: BDTX) Key Stats

The company with the Market Capitalisation of 133.63 million has total of 56,863K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -69,680 K annual income. Company’s last quarter sales were recorded 70,000 K and last quarter income was 56,540 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.